149 related articles for article (PubMed ID: 27466496)
1. Chemotherapeutic Vulnerability of Triple-negative Breast Cancer Cell-derived Tumors to Pretreatment with Vernonia amygdalina Aqueous Extracts.
Howard CB; McDowell R; Feleke K; Deer E; Stamps S; Thames E; Singh V; Pervin S
Anticancer Res; 2016 Aug; 36(8):3933-43. PubMed ID: 27466496
[TBL] [Abstract][Full Text] [Related]
2. Preclinical assessment of vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer.
Yedjou C; Izevbigie E; Tchounwou P
Int J Environ Res Public Health; 2008 Dec; 5(5):337-41. PubMed ID: 19151427
[TBL] [Abstract][Full Text] [Related]
3. In vitro Anticancer Effects of
Joseph J; Khor KZ; Moses EJ; Lim V; Aziz MY; Abdul Samad N
Int J Nanomedicine; 2021; 16():3599-3612. PubMed ID: 34079252
[TBL] [Abstract][Full Text] [Related]
4. Activity markers of the anti-breast carcinoma cell growth fractions of Vernonia amygdalina extracts.
Oyugi DA; Luo X; Lee KS; Hill B; Izevbigie EB
Exp Biol Med (Maywood); 2009 Apr; 234(4):410-7. PubMed ID: 19176872
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of the antibreast carcinoma cell growth components of Vernonia amygdalina extracts.
Luo X; Oyugi DA; Lin C; Izevbigie EB; Lee KS
Exp Biol Med (Maywood); 2010 Dec; 235(12):1472-8. PubMed ID: 20962014
[TBL] [Abstract][Full Text] [Related]
6. The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways.
Wong FC; Woo CC; Hsu A; Tan BK
PLoS One; 2013; 8(10):e78021. PubMed ID: 24205071
[TBL] [Abstract][Full Text] [Related]
7. Vernonia amygdalina: anticancer activity, authentication, and adulteration detection.
Gresham LJ; Ross J; Izevbigie EB
Int J Environ Res Public Health; 2008 Dec; 5(5):342-8. PubMed ID: 19151428
[TBL] [Abstract][Full Text] [Related]
8. Aqueous Vernomia amygdalina extracts alter MCF-7 cell membrane permeability and efflux.
Opata MM; Izevbigie EB
Int J Environ Res Public Health; 2006 Jun; 3(2):174-9. PubMed ID: 16823089
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and mechanisms of taxol-resistant prostate adenocarcinoma cells to Vernonia amygdalina extract.
Cameron KS; Howard CB; Izevbigie EB; Hill BJ; Tchounwou PB
Exp Toxicol Pathol; 2013 Sep; 65(6):759-65. PubMed ID: 23238229
[TBL] [Abstract][Full Text] [Related]
10. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
11. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
Speyer CL; Bukhsh MA; Jafry WS; Sexton RE; Bandyopadhyay S; Gorski DH
Breast Cancer Res Treat; 2017 Nov; 166(2):407-419. PubMed ID: 28780701
[TBL] [Abstract][Full Text] [Related]
12. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
[TBL] [Abstract][Full Text] [Related]
13. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
14. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells.
Burnett JP; Lim G; Li Y; Shah RB; Lim R; Paholak HJ; McDermott SP; Sun L; Tsume Y; Bai S; Wicha MS; Sun D; Zhang T
Cancer Lett; 2017 May; 394():52-64. PubMed ID: 28254410
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
19. St. John's Wort Suppresses Growth in Triple-Negative Breast Cancer Cell Line MDA-MB-231 by Inducing Prodeath Autophagy and Apoptosis.
You M; Lee YH; Kim HJ; Kook JH; Kim HA
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080824
[TBL] [Abstract][Full Text] [Related]
20. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
